Enrolling by Invitation
Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network
NCT07445347
- Conditions
- Bevacizumab, Cardiovascular Abnormalities, Cardiovascular Diseases, +16 more
- Locations
-
- Centre hospitalier universitaire de Poitiers Poitiers, France